Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Effects of C-type Natriuretic Peptide and its Receptors on Sinoatrial Node and Atrial Arrhythmogenesis in Hypertensive Heart Disease

FY 2022-23

Summary
A regular heartbeat ensures adequate blood is supplied to the body. Each heartbeat is initiated by the sinoatrial node (SAN), an area of the heart which acts as a natural pacemaker. Normal SAN function is important for proper electrical activation of the atria (upper chambers of the heart) and maintenance of regular heartbeats. High blood pressure (hypertension) results in damage to the SAN and atria that can lead to irregular heartbeats (arrhythmias) such as SAN disease and atrial fibrillation (AF). Currently, arrhythmia treatment options are limited and associated with undesirable side effects. Natriuretic peptides (NP) are a family of hormones with therapeutic potential. Previous work in our lab suggests that C-type Natriuretic Peptide (CNP) can protect against the development of SAN disease and AF in mouse models of hypertension. However, the mechanisms behind the protective effects of CNP remain poorly understood. CNP causes its effects by binding to two types of receptors: NPR-B and NPR-C. These receptors work in different ways and the distinct roles of NPR-B and NPR-C in mediating the protective effects of CNP are unknown. Thus, our objective is to investigate the effects of CNP on the prevention of arrhythmias in hypertensive heart disease. To do so, the effects of CNP on SAN disease and AF susceptibility will be measured in hypertensive mice and in mice lacking NPR-B or NPR-C. Equal numbers of male and female mice will be used to assess for sex differences. These experiments will clarify how CNP and its receptors protect against hypertension-induced AF, SAN disease and atrial remodelling. This essential information could lead to the development and use of synthetic natriuretic peptides for the treatment of SAN disease and AF in patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486217
Name
Rougier Elise C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of C-type Natriuretic Peptide and its Receptors on Sinoatrial Node and Atrial Arrhythmogenesis in Hypertensive Heart Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arrhythmia; Atrial Fibrillation; Electrophysiology; Fibrosis; Heart; Hypertension; Natriuretic Peptide Receptor; Natriuretic Peptides; Sinoatrial Node Disease; Therapeutics
Abstract
A regular heartbeat ensures adequate blood is supplied to the body. Each heartbeat is initiated by the sinoatrial node (SAN), an area of the heart which acts as a natural pacemaker. Normal SAN function is important for proper electrical activation of the atria (upper chambers of the heart) and maintenance of regular heartbeats. High blood pressure (hypertension) results in damage to the SAN and atria that can lead to irregular heartbeats (arrhythmias) such as SAN disease and atrial fibrillation (AF). Currently, arrhythmia treatment options are limited and associated with undesirable side effects. Natriuretic peptides (NP) are a family of hormones with therapeutic potential. Previous work in our lab suggests that C-type Natriuretic Peptide (CNP) can protect against the development of SAN disease and AF in mouse models of hypertension. However, the mechanisms behind the protective effects of CNP remain poorly understood. CNP causes its effects by binding to two types of receptors: NPR-B and NPR-C. These receptors work in different ways and the distinct roles of NPR-B and NPR-C in mediating the protective effects of CNP are unknown. Thus, our objective is to investigate the effects of CNP on the prevention of arrhythmias in hypertensive heart disease. To do so, the effects of CNP on SAN disease and AF susceptibility will be measured in hypertensive mice and in mice lacking NPR-B or NPR-C. Equal numbers of male and female mice will be used to assess for sex differences. These experiments will clarify how CNP and its receptors protect against hypertension-induced AF, SAN disease and atrial remodelling. This essential information could lead to the development and use of synthetic natriuretic peptides for the treatment of SAN disease and AF in patients.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rougier, Elise C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~